S. Chilton

Low‐dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue

P. Lorigan, P. Johnson, D. Linch, 2007, British journal of haematology.

subsequent radioimmunotherapy lymphoma: the effect of prior rituximab dosing and tumor burden on Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell

M. Cragg, M. Glennie, V. Lewington, 2013 .

Phase 1/2 study of fractionated (131)I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy.

T. Illidge, M. Cragg, M. Glennie, 2009, Blood.